share_log

復宏漢霖:自願公告 - 地舒單抗生物類似藥HLX14(重組抗RANKL全人單克隆抗體注射液)成功完成1期臨床研究

HENLIUS: VOLUNTARY ANNOUNCEMENT - THE PHASE 1 CLINICAL STUDY OF A BIOSIMILAR OF DENOSUMAB HLX14 (RECOMBINANT ANTI-RANKL HUMAN MONOCLONAL ANTIBODY INJECTION) SUCCESSFULLY COMPLETED

香港交易所 ·  Feb 1 03:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more